Gynecologic Oncology | Addressing Current Questions and Emerging Considerations with the Use of PARP Inhibitors in the Management of Ovarian Cancer - a podcast by Dr Neil Love
from 2019-06-18T16:00
::
::
Faculty presentations from an independent satellite symposium during the Society of Gynecologic Oncology’s 2019 Annual Meeting on Women’s Cancer. Featuring perspectives from Dr Robert L Coleman, Prof Jonathan A Ledermann, Dr Stephanie Lheureux and Dr Kathleen Moore:
- Genomic Testing and Management of Primary Ovarian Cancer — Dr Moore (00:00)
- Role of PARP Inhibition in the Management of Relapsed Ovarian Cancer — Prof Ledermann (10:37)
- Prevention, Recognition and Management of PARP Inhibitor-Associated Side Effects — Dr Coleman (21:04)
- Investigational Applications of Approved PARP Inhibitors; Other PARP Inhibitors in Clinical Development — Dr Lheureux (29:33)
Further episodes of Research To Practice | Oncology Videos
Further podcasts by Dr Neil Love
Website of Dr Neil Love